Novo Holdings to Acquire Denmark Based Ellab from EQT

Novo Holdings A/S, a leading global life sciences investor, announced that it has agreed to acquire Ellab from EQT Headquartered in Hillerød, Denmark, Ellab (Ellab) provides validation and monitoring solutions and services for biotech...

Maharashtra Govt signs MoU with Multinational Pharma Firm to Improve Stroke Care

The Government of Maharashtra health department has inked a Memorandum of Understanding (MoU) with multinational pharmaceutical manufacturer Boehringer Ingelheim India to use Artificial Intelligence to improve stroke care at government...

ICMR Soon to Start Research On Ambulatory Care for NCDs in Public Health Care Systems in India

The Indian Council of Medical Research (ICMR) has invited Expression of Interest (EOI) for Implementation Research Study on Ambulatory Care for Non-Communicable Diseases (NCDs) in Public Health Care Systems in India...

US FDA Approves Zynex's CM-1600 Monitor for Improved Blood & Fluid Management

Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has announced that the FDA has granted 510(k) market...

Pharma Exports Expected to Touch $28 billion in FY 24: Pharmexcil Chief

Udaya Bhaskar, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), a body under the Department of Commerce, predicted on Tuesday that Indian pharmaceutical exports could reach USD 28 billion in the current fiscal..

WHO Approves Emergency Use Listing to SK bioscience's Covid-19 vaccine, SKYCovione

SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health from prevention to cure, announced that its Covid-19 vaccine, SKYCovione, has received the WHO Emergency Use Listing....

Mankind Pharma Receives a Flood Of Buy Calls Following a 57% Increase since its IPO

Mankind Pharma Ltd. has received the most analyst coverage of any new Indian stock in at least 12 years, as investors rush to purchase the drugmaker's shares following a blockbuster IPO in May. Since its initial public offering, the company's...

Aldeyra Therapeutics Introduces phase 3 INVIGORATE-2 trial of reproxalap to treat allergic conjunctivitis meets primary and secondary endpoints

ldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, announced positive top-line results from the phase 3 INVIGORATE-2 clinical trial...

US FDA Granted Biostar Pharma's IND Application to Initiate Phase 2/3 Trial of Utidelone Injectable to Treat NSCLC

US FDA Granted Biostar Pharma’s IND Application to Iiostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. announced that, after having in-depth discussions with the FDA through pre-IND meetings, the FDA has approved...

Lupin Introduces Thiamine Hydrochloride Injection USP in US markets

Global pharma major Lupin Limited (Lupin) announced the launch of thiamine hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) multiple-dose vials, after Lupin’s alliance partner Caplin Steriles Limited (Caplin) received an approval for its ANDA....

© 2024 India Pharma Outlook. All Rights Reserved.